# Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

> **NCT07055880** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 120 (estimated)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** Rabies Vaccine (Serum-free Vero Cell), Freeze-dried
- **BIOLOGICAL:** Verorab®

## Key facts

- **NCT ID:** NCT07055880
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-28
- **Primary completion:** 2026-01-15
- **Final completion:** 2026-01-15
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07055880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07055880, "Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07055880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*